OptiVitro® T-SFM series facilicate different kinds of application scenarios, and support seamless transition from research to clinical scale. Customized packing sizes and formulations are also available.
1. Serum-free, xeno-free, work without any serum replacement.
2. Robust T Cell expansion with high viability during 14 days of culture.3. Batch to batch consistency, scalability for clinical and commercialization.
4. Provided in bottle or bag format, suitable for different kinds of activation methods.
5. Independent research and development, stable supply.
6. Provide customized service to fit your workflow needs.
7. GMP grade, facilitate regulatory approval (DMF code 037572).
